BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 25350764)

  • 1. Prenatal and preconception population carrier screening for cystic fibrosis in Australia: where are we up to?
    Massie J; Ioannou L; Delatycki M
    Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):503-9. PubMed ID: 25350764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB
    J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience.
    Massie J; Petrou V; Forbes R; Curnow L; Ioannou L; Dusart D; Bankier A; Delatycki M
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):484-9. PubMed ID: 19780730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based genetic screening for cystic fibrosis: attitudes and outcomes.
    Ioannou L; Massie J; Collins V; McClaren B; Delatycki MB
    Public Health Genomics; 2010; 13(7-8):449-56. PubMed ID: 20090299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of population cystic fibrosis prenatal and preconception carrier screening among individuals with cystic fibrosis and their family members.
    Maxwell SJ; Kyne G; Molster C; Barker NM; Ormsby J; O'Leary P
    Genet Test Mol Biomarkers; 2011 Mar; 15(3):159-64. PubMed ID: 21204697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Suddenly Having two Positive People who are Carriers is a Whole New Thing" - Experiences of Couples Both Identified as Carriers of Cystic Fibrosis Through a Population-Based Carrier Screening Program in Australia.
    Ioannou L; Delatycki MB; Massie J; Hodgson J; Lewis S
    J Genet Couns; 2015 Dec; 24(6):987-1000. PubMed ID: 25925605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing medical practitioner participation in population carrier screening for cystic fibrosis.
    Valente GM; Amor DJ; Ioannou LJ; Archibald AD
    Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):232-238. PubMed ID: 33135161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of prenatal carrier screening for cystic fibrosis.
    Lieu TA; Watson SE; Washington AE
    Obstet Gynecol; 1994 Dec; 84(6):903-12. PubMed ID: 7970468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis carrier screening.
    Massie J; Delatycki MB
    Paediatr Respir Rev; 2013 Dec; 14(4):270-5. PubMed ID: 23466339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on population-based preconception and prenatal cystic fibrosis carrier screening.
    Nolen AA; Rhoades ED
    J Okla State Med Assoc; 2003 Oct; 96(10):482-4. PubMed ID: 14619603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(4):1-398. PubMed ID: 37637488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis.
    Arch Intern Med; 1999 Jul; 159(14):1529-39. PubMed ID: 10421275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis carrier screening: knowledge and attitudes of prenatal care providers.
    Rowley PT; Loader S; Levenkron JC; Phelps CE
    Am J Prev Med; 1993; 9(5):261-6. PubMed ID: 8257614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services.
    Henneman L; Bramsen I; van Kempen L; van Acker MB; Pals G; van der Horst HE; Adèr HJ; van der Ploeg HM; ten Kate LP
    Community Genet; 2003; 6(1):5-13. PubMed ID: 12748433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for cystic fibrosis carrier state.
    Mennuti MT; Thomson E; Press N
    Obstet Gynecol; 1999 Mar; 93(3):456-61. PubMed ID: 10075000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of carrier screening for cystic fibrosis in Australia.
    Norman R; van Gool K; Hall J; Delatycki M; Massie J
    J Cyst Fibros; 2012 Jul; 11(4):281-7. PubMed ID: 22425241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier screening for cystic fibrosis in a prenatal setting.
    Delvaux I; van Tongerloo A; Messiaen L; Van Loon C; De Bie S; Mortier G; De Paepe A
    Genet Test; 2001; 5(2):117-25. PubMed ID: 11551097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of a cystic fibrosis carrier testing clinic for couples.
    Christie LM; Ingrey AJ; Turner GM; Proos AL; Watts GE
    Med J Aust; 2009 Nov; 191(9):499-501. PubMed ID: 19883345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis carrier population screening in the primary care setting.
    Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
    Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening.
    Cunningham F; Lewis S; Curnow L; Glazner J; Massie J
    J Cyst Fibros; 2014 Jan; 13(1):99-105. PubMed ID: 23891279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.